# Case Report: Cavitary Legionella pneumophila pneumonia in a kidney transplant recipient: mNGS-guided diagnosis and prolonged combination therapy

**Authors:** Junhong Liu, Yu Zhou, Feilong Xu, Wei Liu, Huaizhou Chen, Qiang Yan, Junjun Guo, Liusheng Lai

PMC · DOI: 10.3389/fmed.2026.1697062 · Frontiers in Medicine · 2026-03-12

## TL;DR

A kidney transplant patient developed cavitary Legionella pneumonia, diagnosed using mNGS and successfully treated with prolonged combination therapy.

## Contribution

First documented case in Asia of cavitary Legionella pneumonia in a kidney transplant recipient, highlighting mNGS and combination therapy.

## Key findings

- mNGS identified L. pneumophila in bronchoalveolar lavage fluid, confirming the diagnosis.
- Prolonged dual therapy with azithromycin and levofloxacin led to cavity regression and symptom relief.
- Blood-based mNGS showed declining pathogen reads as the patient recovered.

## Abstract

Legionella pneumophila is an uncommon but potentially life-threatening cause of pneumonia in solid organ transplant (SOT) recipients. Diagnosis is challenging due to nonspecific features and the limited sensitivity of conventional assays. Metagenomic next-generation sequencing (mNGS) offers unbiased detection and may be particularly valuable in immunocompromised hosts with refractory pneumonia. We report the first documented case in Asia of cavitary Legionella pneumonia in a kidney transplant recipient. A 60-year-old man presented with fever and bilateral pulmonary nodules 5 months post-transplant. Despite empirical antifungal and antibacterial therapy, his condition progressed radiologically to cavitary disease. Bronchoalveolar lavage fluid mNGS identified abundant L. pneumophila reads, confirming the diagnosis. Initial azithromycin monotherapy achieved transient improvement but failed to prevent radiological progression. Escalation to prolonged dual therapy with azithromycin and levofloxacin resulted in rapid symptomatic relief, progressive cavity regression on serial computed tomography, and preserved allograft function. Sequential blood-based mNGS demonstrated declining pathogen reads paralleling recovery. This brief research report emphasizes three practice points for SOT recipients with refractory pneumonia: (1) early mNGS can shorten time-to-diagnosis when routine tests are inconclusive; (2) Legionella infection may manifest with atypical cavitary lesions in immunocompromised hosts, warranting scheduled imaging even when symptoms improve; and (3) prolonged macrolide–fluoroquinolone combination therapy may be required for severe or non-resolving cases. Together with our literature review, this case expands understanding of the radiological spectrum, diagnostic strategies, and therapeutic considerations of Legionella pneumonia in transplant populations.

## Linked entities

- **Chemicals:** azithromycin (PubChem CID 447043), levofloxacin (PubChem CID 149096)
- **Diseases:** pneumonia (MONDO:0005249)
- **Species:** Legionella pneumophila (taxon 446)

## Full-text entities

- **Diseases:** cavitary disease (MESH:C566924), fever (MESH:D005334), Legionella pneumonia (MESH:D011014), Legionella infection (MESH:D007877)
- **Chemicals:** fluoroquinolone (MESH:D024841), macrolide (MESH:D018942), levofloxacin (MESH:D064704), azithromycin (MESH:D017963)
- **Species:** Legionella pneumophila (species) [taxon 446]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017911/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13017911/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC13017911/full.md

---
Source: https://tomesphere.com/paper/PMC13017911